{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T11:47:13Z","timestamp":1778672833304,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministry of Education, Science and Technological Development","doi-asserted-by":"crossref","award":["175076"],"award-info":[{"award-number":["175076"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH","award":["R01MH096463"],"award-info":[{"award-number":["R01MH096463"]}]},{"name":"NIH","award":["R01NS076517"],"award-info":[{"award-number":["R01NS076517"]}]},{"name":"Austrian Science Fund","award":["P 27746"],"award-info":[{"award-number":["P 27746"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.euroneuro.2018.05.014","type":"journal-article","created":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T23:01:05Z","timestamp":1529362865000},"page":"903-914","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Attaining in vivo selectivity of positive modulation of \u03b13\u03b2\u03b32 GABAA receptors in rats: A hard task!"],"prefix":"10.1016","volume":"28","author":[{"given":"Bojan","family":"Batini\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Stankovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael Rajesh","family":"Stephen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Revathi","family":"Kodali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veera V.","family":"Tiruveedhula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanguan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Scholze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bojan D.","family":"Markovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandar Lj.","family":"Obradovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margot","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miroslav M.","family":"Savi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2018.05.014_bib0001","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/sj.bjp.0706056","article-title":"Anxiogenic properties of an inverse agonist selective for alpha3 subunit-containing GABA a receptors","volume":"144","author":"Atack","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2018.05.014_bib0002","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1177\/0269881109354927","article-title":"MRK-409 (MK-0343), a GABAA receptor subtype-selective partial agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in humans","volume":"25","author":"Atack","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2018.05.014_bib0003","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bbr.2006.04.006","article-title":"Exploration in a dark open field: a shift from directional to positional progression and a proposed model of acquiring spatial information","volume":"171","author":"Avni","year":"2006","journal-title":"Behav. Brain. Res."},{"key":"10.1016\/j.euroneuro.2018.05.014_bib0004","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1038\/npp.2016.49","article-title":"A pharmacogenetic `restriction-of-function' approach reveals evidence for anxiolytic-like actions mediated by \u03b15-containing GABAA receptors in mice","volume":"41","author":"Behlke","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2018.05.014_bib0005","series-title":"Handbook of Molecular Genetic Techniques for Brain and Behaviour Research (Techniques in the Behavioural and Neural Sciences)","first-page":"739","article-title":"Measuring exploratory behaviour","author":"Belzung","year":"1999"},{"key":"10.1016\/j.euroneuro.2018.05.014_bib0006","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1001\/jamapsychiatry.2013.3059","article-title":"Diversity of neuronal inhibition: a path to novel treatments for neuropsychiatric disorders","volume":"71","author":"Benham","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.euroneuro.2018.05.014_bib0007","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/hup.561","article-title":"Sedation, an unpleasant, undesirable and potentially dangerous side-effect of many psychotropic drugs","volume":"19","author":"Bourin","year":"2004","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2018.05.014_bib0008","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.bbr.2012.09.049","article-title":"Temporal structure of the rat's behavior in elevated plus maze test","volume":"237","author":"Casarrubea","year":"2013","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.euroneuro.2018.05.014_bib0011","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1152\/jn.00539.2013","article-title":"EEG-beta\/gamma spectral power elevation in rat: a translatable biomarker elicited by GABA(Aalpha2\/3)-positive allosteric modulators at nonsedating anxiolytic doses","volume":"113","author":"Christian","year":"2015","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.euroneuro.2018.05.014_bib0012","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.bcp.2014.12.010","article-title":"GABAA \u03b15 subunit-containing receptors do not contribute to reversal of inflammatory-induced spinal sensitization as indicated by the unique selectivity profile of the GABAA receptor allosteric modulator NS16085","volume":"93","author":"de Lucas","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.euroneuro.2018.05.014_bib0013","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.eurpsy.2011.11.003","article-title":"Do benzodiazepines still deserve a major role in the treatment of psychiatric disorders? A critical reappraisal","volume":"28","author":"Dell'osso","year":"2013","journal-title":"Eur. Psychiatry."},{"key":"10.1016\/j.euroneuro.2018.05.014_bib0014","doi-asserted-by":"crossref","first-page":"10682","DOI":"10.1523\/JNEUROSCI.1166-05.2005","article-title":"Evidence for a significant role of alpha 3-containing GABAA receptors in mediating the anxiolytic effects of benzodiazepines","volume":"25","author":"Dias","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2018.05.014_bib0015","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1742-7843.2009.00517.x","article-title":"Active-site concentrations of chemicals \u2013 are they a better predictor of effect than plasma\/organ\/tissue concentrations?","volume":"106","author":"Hammarlund-Udenaes","year":"2010","journal-title":"Basic. Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.euroneuro.2018.05.014_bib0016","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2125.2012.04418.x","article-title":"Benzodiazepine harm: how can it be reduced?","volume":"77","author":"Lader","year":"2014","journal-title":"Br. J. Clin. Pharmacol"},{"key":"10.1016\/j.euroneuro.2018.05.014_bib0017","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/75761","article-title":"Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype","volume":"3","author":"McKernan","year":"2000","journal-title":"Nat. Neurosci."},{"issue":"Supplement","key":"10.1016\/j.euroneuro.2018.05.014_bib0018","first-page":"661.1","article-title":"Role of alpha 3 subunit-containing GABA(A) receptors in benzodiazepine (BZ)-related anti-conflict, reinforcing, and cognitive effects","volume":"27","author":"Meng","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.euroneuro.2018.05.014_bib0019","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.talanta.2009.06.074","article-title":"Simultaneous analysis of diazepam and its metabolites in rat plasma and brain tissue by HPLC-UV and SPE","volume":"80","author":"Mercolini","year":"2009","journal-title":"Talanta"},{"key":"10.1016\/j.euroneuro.2018.05.014_bib0020","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/FBP.0b013e3283512c85","article-title":"The role of \u03b11 and \u03b15 subunit-containing GABAA receptors in motor impairment induced by benzodiazepines in rats","volume":"23","author":"Mili\u0107","year":"2012","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.euroneuro.2018.05.014_bib0021","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bmc.2012.10.057","article-title":"Search for \u03b13\u03b2\/\u03b32 subtype selective ligands that are stable on human liver microsomes","volume":"21","author":"Namjoshi","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.euroneuro.2018.05.014_bib0022","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.brainres.2014.01.036","article-title":"Sh-I-048A, an in vitro non-selective super-agonist at the benzodiazepine site of GABAA receptors: the approximated activation of receptor subtypes may explain behavioral effects","volume":"1554","author":"Obradovi\u0107","year":"2014","journal-title":"Brain. Res."},{"key":"10.1016\/j.euroneuro.2018.05.014_bib0023","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1124\/pr.108.00505","article-title":"International union of pharmacology. LXX. subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function","volume":"60","author":"Olsen","year":"2008","journal-title":"Update Pharmacol. Rev"},{"key":"10.1016\/j.euroneuro.2018.05.014_bib0024","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","article-title":"The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review","volume":"463","author":"Prut","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2018.05.014_bib0025","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.tips.2008.07.005","article-title":"Animal models of anxiety: do I need multiple tests","volume":"29","author":"Ramos","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.euroneuro.2018.05.014_bib0026","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1517\/17425250903559873","article-title":"Assessing brain free fraction in early drug discovery","volume":"6","author":"Read","year":"2010","journal-title":"Expert Opin. Drug. Metab. Toxicol."},{"key":"10.1016\/j.euroneuro.2018.05.014_bib0027","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/44579","article-title":"Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes","volume":"401","author":"Rudolph","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.euroneuro.2018.05.014_bib0028","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev.pharmtox.44.101802.121429","article-title":"Analysis of GABAA receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics","volume":"44","author":"Rudolph","year":"2004","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.euroneuro.2018.05.014_bib0029","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/sj.npp.1301403","article-title":"Are GABAA receptors containing alpha5 subunits contributing to the sedative properties of benzodiazepine site agonists?","volume":"33","author":"Savi\u0107","year":"2008","journal-title":"Neuropsychopharmacology."},{"key":"10.1016\/j.euroneuro.2018.05.014_bib0030","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.pnpbp.2010.01.004","article-title":"Novel positive allosteric modulators of GABAA receptors: do subtle differences in activity at alpha1 plus alpha5 versus alpha2 plus alpha3 subunits account for dissimilarities in behavioral effects in rats?","volume":"34","author":"Savi\u0107","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2018.05.014_bib0031","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.1016\/j.drugalcdep.2014.02.548","article-title":"Role of \u03b13GABAA receptor modulation in the anti-conflict effects of benzodiazepine-type drugs in monkeys","volume":"140","author":"Sawyer","year":"2014","journal-title":"Drug Alcohol. Depend."},{"key":"10.1016\/j.euroneuro.2018.05.014_bib0032","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.tips.2012.08.003","article-title":"Anxioselective anxiolytics: on a quest for the Holy Grail","volume":"33","author":"Skolnick","year":"2012","journal-title":"Trends Pharmacol. Sci"},{"key":"10.1016\/j.euroneuro.2018.05.014_bib0033","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.neuropharm.2012.03.001","article-title":"Benzodiazepine-induced anxiolysis and reduction of conditioned fear are mediated by distinct GABAA receptor subtypes in mice","volume":"63","author":"Smith","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2018.05.014_bib0034","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1177\/0269881107073199","article-title":"The open field test: reinventing the wheel","volume":"21","author":"Stanford","year":"2007","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2018.05.014_bib0035","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2307\/1420860","article-title":"Effects of strain, sex, and illumination on open-field behavior of rats","volume":"83","author":"Valle","year":"1970","journal-title":"Am. J. Psychol."},{"key":"10.1016\/j.euroneuro.2018.05.014_bib0036","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1037\/0033-2909.83.3.482","article-title":"The Open-Field Test: a critical review","volume":"83","author":"Walsh","year":"1976","journal-title":"Psychol. Bull."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X18301299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X18301299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:51:28Z","timestamp":1760377888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X18301299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0924977X18301299"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2018.05.014","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Attaining in vivo selectivity of positive modulation of \u03b13\u03b2\u03b32 GABAA receptors in rats: A hard task!","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2018.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}